BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

823 related articles for article (PubMed ID: 18813320)

  • 21. The role of the hedgehog signaling pathway in the development of basal cell carcinoma and opportunities for treatment.
    Caro I; Low JA
    Clin Cancer Res; 2010 Jul; 16(13):3335-9. PubMed ID: 20439455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Harnessing hedgehog for the treatment of basal cell carcinoma.
    Harms KL; Dlugosz AA
    JAMA Dermatol; 2013 May; 149(5):607-8. PubMed ID: 23677088
    [No Abstract]   [Full Text] [Related]  

  • 23. Sonic Hedgehog Pathway Inhibition in the Treatment of Advanced Basal Cell Carcinoma.
    Leavitt E; Lask G; Martin S
    Curr Treat Options Oncol; 2019 Nov; 20(11):84. PubMed ID: 31773379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical treatment of Basal cell carcinomas in nevoid Basal cell carcinoma syndrome with a smoothened inhibitor.
    Skvara H; Kalthoff F; Meingassner JG; Wolff-Winiski B; Aschauer H; Kelleher JF; Wu X; Pan S; Mickel L; Schuster C; Stary G; Jalili A; David OJ; Emotte C; Antunes AM; Rose K; Decker J; Carlson I; Gardner H; Stuetz A; Bertolino AP; Stingl G; De Rie MA
    J Invest Dermatol; 2011 Aug; 131(8):1735-44. PubMed ID: 21430703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Basal cell carcinoma and its development: insights from radiation-induced tumors in Ptch1-deficient mice.
    Mancuso M; Pazzaglia S; Tanori M; Hahn H; Merola P; Rebessi S; Atkinson MJ; Di Majo V; Covelli V; Saran A
    Cancer Res; 2004 Feb; 64(3):934-41. PubMed ID: 14871823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beyond the scalpel: targeting hedgehog in skin cancer prevention.
    Rudin CM
    Cancer Prev Res (Phila); 2010 Jan; 3(1):1-3. PubMed ID: 20051365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Basal cell carcinoma: hedgehog pathway inhibitors and beyond.
    Walls B
    Cutis; 2013 Jun; 91(6):E1-4. PubMed ID: 23837158
    [No Abstract]   [Full Text] [Related]  

  • 28. Tumor-Derived Suppressor of Fused Mutations Reveal Hedgehog Pathway Interactions.
    Urman NM; Mirza A; Atwood SX; Whitson RJ; Sarin KY; Tang JY; Oro AE
    PLoS One; 2016; 11(12):e0168031. PubMed ID: 28030567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MTOR promotes basal cell carcinoma growth through atypical PKC.
    Chow RY; Levee TM; Kaur G; Cedeno DP; Doan LT; Atwood SX
    Exp Dermatol; 2021 Mar; 30(3):358-366. PubMed ID: 33617094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antitumoral effects of calcitriol in basal cell carcinomas involve inhibition of hedgehog signaling and induction of vitamin D receptor signaling and differentiation.
    Uhmann A; Niemann H; Lammering B; Henkel C; Hess I; Nitzki F; Fritsch A; Prüfer N; Rosenberger A; Dullin C; Schraepler A; Reifenberger J; Schweyer S; Pietsch T; Strutz F; Schulz-Schaeffer W; Hahn H
    Mol Cancer Ther; 2011 Nov; 10(11):2179-88. PubMed ID: 21878656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hedgehog Pathway Inhibition for the Treatment of Basal Cell Carcinoma.
    Gutzmer R; Solomon JA
    Target Oncol; 2019 Jun; 14(3):253-267. PubMed ID: 31243642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting the hedgehog pathway to treat basal cell carcinoma.
    Geeraert P; Williams JS; Brownell I
    J Drugs Dermatol; 2013 May; 12(5):519-23. PubMed ID: 23652945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging treatments and signaling pathway inhibitors.
    Tang JY; Marghoob AA
    Semin Cutan Med Surg; 2011 Dec; 30(4 Suppl):S14-8. PubMed ID: 22177102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sheep, lilies and human genetics.
    Bale AE
    Nature; 2000 Aug; 406(6799):944-5. PubMed ID: 10984033
    [No Abstract]   [Full Text] [Related]  

  • 35. [Targeted therapy of basal cell carcinoma through inhibition of the hedgehog signaling pathway].
    Hafner C
    Hautarzt; 2010 Apr; 61(4):356-8. PubMed ID: 20309511
    [No Abstract]   [Full Text] [Related]  

  • 36. Precision medicine and precision therapeutics: hedgehog signaling pathway, basal cell carcinoma and beyond.
    Mohan SV; Chang AL
    Semin Cutan Med Surg; 2014 Jun; 33(2):68-71. PubMed ID: 25085664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Basal cell carcinoma of the skin (part 1): epidemiology, pathology and genetic syndromes.
    Correia de Sá TR; Silva R; Lopes JM
    Future Oncol; 2015 Nov; 11(22):3011-21. PubMed ID: 26449153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SOX9 Transcriptionally Regulates mTOR-Induced Proliferation of Basal Cell Carcinomas.
    Kim AL; Back JH; Chaudhary SC; Zhu Y; Athar M; Bickers DR
    J Invest Dermatol; 2018 Aug; 138(8):1716-1725. PubMed ID: 29550418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vismodegib: a hedgehog pathway inhibitor for locally advanced and metastatic basal cell carcinomas.
    Sobanko JF; Okman J; Miller C
    J Drugs Dermatol; 2013 Oct; 12(10 Suppl):s154-5. PubMed ID: 24085062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Inhibitors of the Hedgehog signalling pathway: hope for the treatment of basal cell carcinoma].
    Vidal V
    Med Sci (Paris); 2010 Mar; 26(3):231-3. PubMed ID: 20346268
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.